Bionomics Limited

Bionomics Limitedverified

BNOX

Price:

$0.6418

Market Cap:

$7.65M

Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia and the United States. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which has completed phase 2 clinical trial for the treatment of social anxiety disorder and post-traumatic stress disorder. It also develops BNC375, a small molecule therapeutics for the treatment of cognitive impairment in Alzheimer's disease; BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, a ...[Read more]

Industry

Biotechnology

IPO Date

2021-12-16

Stock Exchange

NASDAQ

Ticker

BNOX

The PE Ratio as of September 2024 (TTM) for Bionomics Limited (BNOX) is -0.31

According to Bionomics Limited’s latest financial reports and current stock price. The company's current PE Ratio is -0.31. This represents a change of -61.17% compared to the average of -0.80 of the last 4 quarters.

Bionomics Limited (BNOX) Historical PE Ratio (quarterly & annually)

How has BNOX PE Ratio performed in the past?

The mean historical PE Ratio of Bionomics Limited over the last ten years is -5.39. The current -0.31 PE Ratio has changed 475.10% with respect to the historical average. Over the past ten years (40 quarters), BNOX's PE Ratio was at its highest in in the June 2019 quarter at 11.94. The PE Ratio was at its lowest in in the December 2020 quarter at -1532.31.

Quarterly (TTM)
Annual

Average

-5.39

Median

-4.43

Minimum

-11.10

Maximum

-0.85

Bionomics Limited (BNOX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Bionomics Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 174.18%

Maximum Annual PE Ratio = -0.85

Minimum Annual Increase = -72.01%

Minimum Annual PE Ratio = -11.10

Quarterly (TTM)
Annual
YearPE RatioChange
2023-0.85-69.91%
2022-2.81-71.26%
2021-9.79-11.85%
2020-11.1090.51%
2019-5.83174.18%
2018-2.13-72.01%
2017-7.59150.83%

Bionomics Limited (BNOX) Average PE Ratio

How has BNOX PE Ratio performed in the past?

The current PE Ratio of Bionomics Limited (BNOX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-4.48

5-year avg

-6.08

10-year avg

-5.39

Bionomics Limited (BNOX) PE Ratio vs. Peers

How is BNOX’s PE Ratio compared to its peers?

Bionomics Limited’s PE Ratio is less than Accustem Sciences Inc. (0), less than Hillstream BioPharma, Inc. (-0.00), less than Comera Life Sciences Holdings, Inc. (-0.00), less than SciSparc Ltd. (-0.01), less than Anebulo Pharmaceuticals, Inc. (-0.02), greater than PMV Pharmaceuticals, Inc. (-5.55), greater than Miromatrix Medical Inc. (-1.59), greater than ZIVO Bioscience, Inc. (-3.41), greater than Aerovate Therapeutics, Inc. (-3.13), greater than Adagene Inc. (-0.62), greater than Acrivon Therapeutics, Inc. Common Stock (-2.32), greater than Rezolute, Inc. (-3.96), greater than AN2 Therapeutics, Inc. (-4.25), greater than null (-0.49),

Build a custom stock screener for Bionomics Limited (BNOX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bionomics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bionomics Limited (BNOX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bionomics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Bionomics Limited's PE Ratio?

How is the PE Ratio calculated for Bionomics Limited (BNOX)?

What is the highest PE Ratio for Bionomics Limited (BNOX)?

What is the 3-year average PE Ratio for Bionomics Limited (BNOX)?

What is the 5-year average PE Ratio for Bionomics Limited (BNOX)?

How does the current PE Ratio for Bionomics Limited (BNOX) compare to its historical average?